Latest filing published 25 Feb 2010 for KAYDON CORP.
No signal scores available.
This profile gathers the share dealings of Donald Buzinkai across 2 companies, led by Alpharma Inc and Kaydon Corp. Over a trading history stretching from 17 September 2007 to 23 February 2010, the count stands at 8 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 25 February 2010 came the latest disclosure, a share grant in Kaydon Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations